Proteomic analysis of extremely severe hand, foot and mouth disease infected by enterovirus 71

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Deng, Li ^a   Jia, Hong Ling ^b   Liu, Chao Wu ^d   Xu, Yu Fen ^a   Mao, Li Jia ^a   He, Chun Hui ^a   Yin, Gen Quan ^a   Lin, Jun Hong ^a   Tao, Jian Ping ^a   Zhu, Li ^c  

^a GUANGZHOU WOMEN AND CHILDREN S MEDICAL CENTER   (China)

^b JINAN UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d GUANGDONG INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

Extremely severe HFMD; MALDI TOF TOF MS; Proteomic analysis

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN; APOLIPOPROTEIN A1; CERULOPLASMIN; CLUSTERIN; COMPLEMENT COMPONENT C3; FICOLIN; HAPTOGLOBIN; HEMOPEXIN; IMMUNOGLOBULIN HEAVY CHAIN; INTER ALPHA TRYPSIN INHIBITOR; KERATIN; PEROXIREDOXIN; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMINOGEN; RETINOL BINDING PROTEIN 4; SERUM AMYLOID P;

ARTICLE; BLOOD SAMPLING; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROVIRUS 71; HAND FOOT AND MOUTH DISEASE; HUMAN; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 84883011075     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-383     Document Type: Article

References (29)

1. Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974, 129(3):304-309. 10.1093/infdis/129.3.304, 4361245.
2. Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, Lim WL, Ong BB, Paul G, AbuBakar S, Lambert M. Fatal enterovirus 71 encephalomyelitis. J Pediatr 1998, 133(6):795-798. 10.1016/S0022-3476(98)70155-6, 9842048.
3. Lum LC, Wong KT, Lam SK, Chua KB, Goh AY. Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet 1998, 352(9137):1391.
4. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 1999, 341(13):929-935. 10.1056/NEJM199909233411301, 10498487.
5. Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 2003, 9(1):78-85. 10.3201/eid0901.020112, 2873753, 12533285.
6. Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L, et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong. China. J Clin Virol 2009, 44(4):262-267.
7. Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 2008, 7:94.
8. Jia L, Zhao CS, Zhang L, Li S, Zhang DT, Liu BW, Wang QY, Li XY. [Comparisons of epidemiological and clinical characteristics in children with hand-foot-mouth disease caused by Enterovirus 71 and Coxackievirus A16]. Zhongguo Dang Dai Er Ke Za Zhi 2011, 13(8):635-637.
9. Wang X, Zhu C, Bao W, Zhao K, Niu J, Yu XF, Zhang W. Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One 2012, 7(3):e32405. 10.1371/journal.pone.0032405, 3315555, 22479324.
10. Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther 2009, 7(6):735-742. 10.1586/eri.09.45, 19681701.
11. Chen SC, Chang HL, Yan TR, Cheng YT, Chen KT. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg 2007, 77(1):188-191.
12. Briese T, Palacios G, Kokoris M, Jabado O, Liu Z, Renwick N, Kapoor V, Casas I, Pozo F, Limberger R, et al. Diagnostic system for rapid and sensitive differential detection of pathogens. Emerg Infect Dis 2005, 11(2):310-313. 10.3201/eid1102.040492, 3320438, 15752453.
13. Foo DG, Ang RX, Alonso S, Chow VT, Quak SH, Poh CL. Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots. Clin Microbiol Infect 2008, 14(3):286-288. 10.1111/j.1469-0691.2007.01904.x, 18076666.
14. Wang SY, Lin TL, Chen HY, Lin TS. Early and rapid detection of enterovirus 71 infection by an IgM-capture ELISA. J Virol Methods 2004, 119(1):37-43. 10.1016/j.jviromet.2004.02.017, 15109819.
15. Xu F, Yan Q, Wang H, Niu J, Li L, Zhu F, He S, Zhang S, Weng Z, Cheng T. Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS One 2010, 5(6):e11388. 10.1371/journal.pone.0011388, 2894942, 20613983.
16. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995, 22(2):432-438.
17. Jia H, Liu C, Ge F, Xiao C, Lu C, Wang T, He Q. Identification of ubiquitinated proteins from human multiple myeloma U266 cells by proteomics. Biomed Environ Sci 2011, 24(4):422-430.
18. Xiao CL, Zhang ZP, Xiong S, Lu CH, Wei HP, Zeng HL, Liu Z, Zhang XE, Ge F. Comparative proteomic analysis to discover potential therapeutic targets in human multiple myeloma. Proteomics Clin Appl 2009, 3(11):1348-1360. 10.1002/prca.200900068, 21136955.
19. Deng L, Jia HL, Liu CW, Hu KH, Yin GQ, Ye JW, He CH, Chen JH, Xie YP, Dang R. Analysis of differentially expressed proteins involved in hand, foot and mouth disease and normal sera. Clin Microbiol Infect 2012, 18(6):E188-196. 10.1111/j.1469-0691.2012.03836.x, 22497606.
20. Enghild JJ, Salvesen G, Thogersen IB, Valnickova Z, Pizzo SV, Hefta SA. Presence of the protein-glycosaminoglycan-protein covalent cross-link in the inter-alpha-inhibitor-related proteinase inhibitor heavy chain 2/bikunin. J Biol Chem 1993, 268(12):8711-8716.
21. Sunthornthepvarakul T, Angkeow P, Weiss RE, Hayashi Y, Refetoff S. An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun 1994, 202(2):781-787. 10.1006/bbrc.1994.1998, 8048949.
22. Ichinose A, Espling ES, Takamatsu J, Saito H, Shinmyozu K, Maruyama I, Petersen TE, Davie EW. Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci U S A 1991, 88(1):115-119. 10.1073/pnas.88.1.115, 50760, 1986355.
23. Sjoberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a delicate balance. Trends Immunol 2009, 30(2):83-90. 10.1016/j.it.2008.11.003, 19144569.
24. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010, 11(9):785-797. 10.1038/ni.1923, 2924908, 20720586.
25. Zhang C, Xu Y, Jia L, Yang Y, Wang Y, Sun Y, Huang L, Qiao F, Tomlinson S, Liu X. A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitor. Virol J 2010, 7:30. 10.1186/1743-422X-7-30, 2829536, 20144216.
26. Shih SR, Stollar V, Lin JY, Chang SC, Chen GW, Li ML. Identification of genes involved in the host response to enterovirus 71 infection. J Neurovirol 2004, 10(5):293-304. 10.1080/13550280490499551, 15385252.
27. Crack PJ, Taylor JM, Flentjar NJ, De Haan J, Hertzog P, Iannello RC, Kola I. Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J Neurochem 2001, 78(6):1389-1399. 10.1046/j.1471-4159.2001.00535.x, 11579147.
28. Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, Ichimiya M, Sengupta S, Mechanic L, Okamura S, et al. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 2004, 64(7):2350-2356. 10.1158/0008-5472.CAN-2287-2, 15059885.
29. Kuku I, Aydogdu I, Bayraktar N, Kaya E, Akyol O, Erkurt MA. Oxidant/antioxidant parameters and their relationship with medical treatment in multiple myeloma. Cell Biochem Funct 2005, 23(1):47-50. 10.1002/cbf.1127, 15386538.